Trial Site Detail

 

Drug:
STA-9090
Trial:
Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

US Oncology - Dayton Oncology & Hematology

3120 Governors Place Blvd.     
Kettering , OH 45409
USA

 

Principal Investigator:
 Robert Raju, MD
Contact:
 robert.raju@usoncology.com (937)293-1622
Activation Status of this Site:
 Closed
Notes about this Site:
US Oncology - Dayton Oncology & Hematology Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.